These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 21848364)

  • 1. HIV type 1 Gag as a target for antiviral therapy.
    Waheed AA; Freed EO
    AIDS Res Hum Retroviruses; 2012 Jan; 28(1):54-75. PubMed ID: 21848364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New therapeutic approaches targeted at the late stages of the HIV-1 replication cycle.
    Jiang Y; Liu X; De Clercq E
    Curr Med Chem; 2011; 18(1):16-28. PubMed ID: 21110817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors.
    Spearman P
    Curr Top Med Chem; 2016; 16(10):1154-66. PubMed ID: 26329615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of structural protein Gag and related gene (protein) in late stages of the HIV-1 replication cycle and the inhibitors].
    Jiang Y; Liu XY
    Yao Xue Xue Bao; 2010 Feb; 45(2):205-14. PubMed ID: 21351430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
    Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
    J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles.
    Nguyen AT; Feasley CL; Jackson KW; Nitz TJ; Salzwedel K; Air GM; Sakalian M
    Retrovirology; 2011 Dec; 8():101. PubMed ID: 22151792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus maturation as a new HIV-1 therapeutic target.
    Adamson CS; Salzwedel K; Freed EO
    Expert Opin Ther Targets; 2009 Aug; 13(8):895-908. PubMed ID: 19534569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396.
    Murgatroyd C; Pirrie L; Tran F; Smith TK; Westwood NJ; Adamson CS
    J Virol; 2016 Sep; 90(18):8181-97. PubMed ID: 27384665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entry inhibitors directed towards glycoprotein gp120: an overview on a promising target for HIV-1 therapy.
    Flores A; Quesada E
    Curr Med Chem; 2013 Feb; 20(6):751-71. PubMed ID: 23278399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel postentry inhibitor of human immunodeficiency virus type 1 replication screened by yeast membrane-associated two-hybrid system.
    Urano E; Kuramochi N; Ichikawa R; Murayama SY; Miyauchi K; Tomoda H; Takebe Y; Nermut M; Komano J; Morikawa Y
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4251-60. PubMed ID: 21746942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein.
    Nangola S; Urvoas A; Valerio-Lepiniec M; Khamaikawin W; Sakkhachornphop S; Hong SS; Boulanger P; Minard P; Tayapiwatana C
    Retrovirology; 2012 Feb; 9():17. PubMed ID: 22348230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in HIV-1 Gag Inhibitor Design and Development.
    Dick A; Cocklin S
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32272714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Characterization of BMS-955176, a Second-Generation HIV-1 Maturation Inhibitor with Improved Potency, Antiviral Spectrum, and Gag Polymorphic Coverage.
    Nowicka-Sans B; Protack T; Lin Z; Li Z; Zhang S; Sun Y; Samanta H; Terry B; Liu Z; Chen Y; Sin N; Sit SY; Swidorski JJ; Chen J; Venables BL; Healy M; Meanwell NA; Cockett M; Hanumegowda U; Regueiro-Ren A; Krystal M; Dicker IB
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3956-69. PubMed ID: 27090171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting RNA-protein interactions within the human immunodeficiency virus type 1 lifecycle.
    Bell NM; L'Hernault A; Murat P; Richards JE; Lever AM; Balasubramanian S
    Biochemistry; 2013 Dec; 52(51):9269-74. PubMed ID: 24358934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.
    Urano E; Ablan SD; Mandt R; Pauly GT; Sigano DM; Schneider JP; Martin DE; Nitz TJ; Wild CT; Freed EO
    Antimicrob Agents Chemother; 2016 Jan; 60(1):190-7. PubMed ID: 26482309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Capsid Inhibitors as Antiretroviral Agents.
    Thenin-Houssier S; Valente ST
    Curr HIV Res; 2016; 14(3):270-82. PubMed ID: 26957201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction.
    Tavassoli A; Lu Q; Gam J; Pan H; Benkovic SJ; Cohen SN
    ACS Chem Biol; 2008 Dec; 3(12):757-64. PubMed ID: 19053244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad-Spectrum Antiviral Activity of an Ankyrin Repeat Protein on Viral Assembly against Chimeric NL4-3 Viruses Carrying Gag/PR Derived from Circulating Strains among Northern Thai Patients.
    Sakkhachornphop S; Hadpech S; Wisitponchai T; Panto C; Kantamala D; Utaipat U; Praparattanapan J; Kotarathitithum W; Taejaroenkul S; Yasamut U; Chupradit K; Moonmuang S; Sanghiran Lee V; Suparatpinyo K; Tayapiwatana C
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30428529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide inhibitors of HIV-1 egress.
    Waheed AA; Freed EO
    ACS Chem Biol; 2008 Dec; 3(12):745-7. PubMed ID: 19099395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.